Simplex Trading’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-500
Closed -$122K 10985
2022
Q3
$122K Buy
500
+400
+400% +$108K ﹤0.01% 5248
2022
Q2
$24K Buy
+100
New +$27K ﹤0.01% 7422
2022
Q1
Sell
-1,600
Closed -$574K 11802
2021
Q4
$574K Sell
1,600
-900
-36% -$304K ﹤0.01% 3614
2021
Q3
$782K Buy
2,500
+100
+4% +$33.9K ﹤0.01% 3446
2021
Q2
$749K Buy
2,400
+2,334
+3,536% +$716K ﹤0.01% 3553
2021
Q1
$2.1M Sell
66
-250
-79% -$80K ﹤0.01% 1551
2020
Q4
$10.2M Sell
316
-193
-38% -$53.4K 0.01% 582
2020
Q3
$14.1M Buy
509
+97
+24% +$27.9K 0.02% 400
2020
Q2
$9.95M Buy
412
+94
+30% +$18.9K 0.02% 521
2020
Q1
$4.62M Sell
318
-42
-12% -$6.97K 0.01% 736
2019
Q4
$6.14M Buy
360
+10
+3% +$1.85K 0.01% 677
2019
Q3
$6.23M Buy
350
+59
+20% +$12.8K 0.02% 602
2019
Q2
$7.58M Sell
291
-274
-48% -$72.7K 0.02% 501
2019
Q1
$16.1M Buy
565
+445
+371% +$148K 0.04% 270
2018
Q4
$3.9M Sell
120
-658
-85% -$229K 0.01% 688
2018
Q3
$35M Buy
778
+688
+764% +$271K 0.11% 119
2018
Q2
$3.68M Buy
90
+48
+114% +$17.4K 0.01% 722
2018
Q1
$28K Buy
42
+12
+40% +$3.04K ﹤0.01% 3032
2017
Q4
$15K Buy
+30
New +$5.6K ﹤0.01% 3597
2017
Q2
Sell
-136
Closed -$7K 7027
2017
Q1
$7K Buy
136
+103
+312% +$11.9K ﹤0.01% 4353
2016
Q4
$8K Sell
33
-34
-51% -$3.94K ﹤0.01% 3975
2016
Q3
$17K Buy
+67
New +$8.03K ﹤0.01% 3150
2016
Q2
Sell
-10
Closed -$4K 6653
2016
Q1
$4K Sell
10
-15
-60% -$1.27K ﹤0.01% 4333
2015
Q4
$4K Sell
25
-27
-52% -$2.29K ﹤0.01% 4097
2015
Q3
$37K Buy
52
+41
+373% +$3.61K ﹤0.01% 2241
2015
Q2
$6K Sell
11
-9
-45% -$598 ﹤0.01% 3566
2015
Q1
$2K Buy
+20
New +$1.09K ﹤0.01% 4241

Other funds holding ABMD

Simplex Trading's ABMD Position: Q1 2022 in Review

Simplex Trading sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 4,633 shares — an estimated $1.43M sold.

Simplex Trading first reported a position in ABMD in Q4 2014 and held it in 21 quarters. The position peaked at $9.57M in Q3 2018. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

  • Simplex Trading reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
  • Simplex Trading sold 4,633 Abiomed Inc shares in Q1 2022, an estimated $1.43M.
  • Simplex Trading first reported a position in Abiomed Inc in Q4 2014 and held it in 21 quarters.
  • Simplex Trading's Abiomed Inc position peaked at $9.57M in Q3 2018.
  • 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on Simplex Trading's 13F filing for Q1 2022, filed 2 May 2022.